Drug Shortage Report for TAMSULOSIN CR
| Report ID | 211102 |
| Drug Identification Number | 02427117 |
| Brand name | TAMSULOSIN CR |
| Common or Proper name | TAMSULOSIN CR |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
| Strength(s) | 0.4MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-25 |
| Estimated end date | 2024-08-10 |
| Actual end date | 2024-07-04 |
| Shortage status | Resolved |
| Updated date | 2024-07-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.